Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-22Clinical Trial Update: A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction [Phase 2, Phase 3]
A randomized controlled trial evaluated a low-energy diet to improve functional status in heart failure with preserved ejection fraction (HF…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: Novel Respiratory Training as Part of Palliative Care for Older Adults With Heart Failure [NA]
Trial results report on novel respiratory training as part of palliative care for older adults with heart failure, focusing on aging and fra…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients [Phase 4]
Phase 4 trial evaluating sotagliflozin in heart failure with preserved ejection fraction has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: NMES in HF Patients to Improve Functional Recovery Following Hospitalization [NA]
A completed clinical trial evaluating neuromuscular electrical stimulation (NMES) to aid functional recovery after hospitalization in patien…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV
Completed clinical trial evaluating Adaptive Servo-Ventilation for improving sleep quality in patients with central sleep apnea and heart fa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF [Phase 2]
A Phase 2 trial is evaluating a triple therapy comprising an ARNI, an SGLT2 inhibitor, and a mineralocorticoid receptor antagonist for advan…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy [NA]
A completed clinical trial evaluating the SGLT-2 inhibitor dapagliflozin in patients with amyloid cardiomyopathy across heart failure phenot…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity [Phase 3]
A Phase 3 trial evaluating Maridebart Cafraglutide for heart failure with preserved or mildly reduced ejection fraction in people with obesi…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction [Phase 1, Phase 2]
A clinical trial evaluating colchicine for heart failure with preserved ejection fraction has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Novel Approaches for Improving Vascular Function in Veterans With HFpEF [Phase 1]
A Phase 1 trial in veterans with heart failure with preserved ejection fraction (HFpEF) and inflammation is exploring novel approaches to im…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of LY3971297 in Participants With Heart Failure [Phase 1]
Phase 1 study of LY3971297 in participants with heart failure (including diastolic and systolic subtypes) is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients [Phase 2]
The document reports the completion of an open-label Phase 2 rollover study evaluating levosimendan in patients with pulmonary hypertension …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Selenium Intervention Registry Randomized Trial in Heart Failure [Phase 3]
A Phase 3 randomized trial evaluating selenium supplementation in patients with various forms of heart failure is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Muscle Blood Flow Regulation in HFpEF [NA]
A recruiting clinical trial is studying muscle blood flow regulation in heart failure with preserved ejection fraction.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: OBESE-HFpEF: Towards Preventing Obesity Related HFpEF
This is a clinical trial update for OBESE-HFpEF, a study aimed at preventing obesity-related heart failure with preserved ejection fraction.…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction
A Mayo Clinic-sponsored study is recruiting to examine exercise cardiovascular magnetic resonance imaging in people with heart failure with …
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Predictors of Poor Prognosis in HFpEF
This clinical trial investigates predictors of poor prognosis in heart failure with preserved ejection fraction (HFpEF) and is currently rec…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
A clinical trial update from Johns Hopkins on physical activity and energetic function in healthy individuals and patients with heart failur…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial [Phase 2]
A Phase 2 clinical trial sponsored by the University of Pennsylvania is evaluating an SGLT2 inhibitor in combination with potassium nitrate …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) [Phase 2]
Phase 2 clinical trial update for sotatercept in combined pre- and post-capillary pulmonary hypertension due to heart failure with preserved…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Exercise Testing After Preeclampsia
The document reports that a Vanderbilt University Medical Center study evaluating exercise testing after preeclampsia is currently recruitin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: AI-based Echocardiography for Detection of Cardiac Amyloidosis [NA]
An AI-based echocardiography study aimed at detecting cardiac amyloidosis; the trial status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis
Completed clinical trial evaluating cardiac magnetic resonance T1 mapping for diagnosing cardiac amyloidosis.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial sponsored by Northwestern University is evaluating the effects of dapagliflozin on metabolomics and cardiac mecha…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
A clinical trial named HeartShare aims to integrate omics data, deep phenotyping, and electronic health records to define heart failure subt…